vimarsana.com

Page 146 - கனடா ஓய்வூதியம் திட்டம் முதலீடு பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ZAHL to sell its India focused Animal Health Business to Multiples Alternate Asset Management led consortium

Uniindia: Mumbai, May 12 (UNI) Zydus Animal Health and Investments Limited (ZAHL), a wholly owned material subsidiary of Cadila Healthcare Limited, has entered into a Business Transfer Agreement (BTA) and other Ancillary Agreements (Definitive Agreements) to sell and transfer its Animal Healthcare Established Markets Undertaking to Multiples Alternate Asset Management led consortium.

Equity platform Multiples-led consortium buys Zydus Animal Health biz for Rs 2921 Cr

Equity platform Multiples-led consortium buys Zydus Animal Health biz for Rs 2921 Cr Equity platform Multiples-led consortium buys Zydus Animal Health biz for Rs 2921 Cr 12 May 2021 | News Multiples, along with its consortium partners, will acquire 100% business of Zydus AH through a slump sale transaction Image credit- shutterstock.com Private equity platform Multiples Alternate Asset Management (Multiples) led consortium, through an SPV controlled by them, have signed a Business Transfer Agreement (BTA) and other Ancillary Agreements to acquire Animal Healthcare Established Markets Undertaking (Zydus AH).  The consortium including Multiples, Canada Pension Plan Investment Board (CPP Investments) and RARE Enterprises, is buying the animal health business of Zydus AH focused on India and certain other countries on a going concern basis via a slump sale from Zydus Animal Health and Investments Limited (ZAHL), a wholly owned subsidiary of Cadila Healthcare.

Nifty, Sensex under remains under pressure from global factors – Wednesday closing report

Nifty, Sensex under remains under pressure from global factors – Wednesday closing report Moneylife Digital Team  0 We had mentioned in Tuesday’s closing report that Nifty, Sensex may move sideways. On Wednesday, the indices opened higher but ended in the red with minor losses. On the NSE, there were 887 advances, 1,088 declines and 61 unchanged.   The trends of the major indices in the course of Wednesday’s trading are given in the table below:     Cadila Healthcare has informed the exchanges that a consortium of investors Multiples Alternate Asset Management, Canada Pension Plan Investment Board (CPPIB) and Rakesh Jhunjhunwala-backed Rare Enterprises will buy its animal healthcare business for Rs 2,921 crore. 

Waymo to lose its CFO and head of automotive partnerships – TechCrunch

Waymo’s chief financial officer Ger Dwyer and its head of automotive partnerships and corporate development Adam Frost two longtime executives at the autonomous vehicle company are leaving this month, departures that comes amid some executive shuffling following CEO John Krafcik’s exit earlier this year. Dwyer and Frost’s departure was shared internally this week, […]

Zydus Cadila to sell one animal health business for Rs 2,921 crore

Zydus Cadila to sell one animal health business for Rs 2,921 crore ANI | Updated: May 12, 2021 12:27 IST Ahmedabad (Gujarat) [India], May 12 (ANI): Pharmaceutical major Zydus Cadila said on Wednesday it has signed agreements to sell one of its animal health business companies to Multiples Alternate Asset Management led consortium for Rs 2,921 crore. The consortium includes Canada Pension Plan Investment Board and RARE Enterprises. The slump sale transaction is expected to be complete within 90 days. Zydus Animal Health and Investments Ltd (ZAHL) has leadership position across a wide spectrum of therapeutic and nutritional products for livestock and poultry animal segments. It employs 700 people and has one manufacturing facility in Haridwar.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.